2. Des Jarlais DC, Lyles C, Crepaz N. the TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TERND statement. Am J Public Health. 2004; 94:361–366.
3. Hwang YW, Lee KW, Hwang IH, Kim SY. The quality of reporting of randomized controlled trials in Korean medical journals indexed in KoreaMed: Survey of items of the revised CONSORT statement. J Korean Acad Fam Med. 2008; 29:276–282.
4. Jüni P, Altman DG, Egger M. Systematic reviews in healthcare: Assessing the quality of controlled clinical trials. BMJ. 2001; 323:42–46.
7. Lachin JM. Statistical considerations in the intent-totreat principle. Control Clin Trials. 2000; 21:167–189.
Article
8. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomized trials. Int J Surg. 2012; 10:28–55.
http://dx.doi.org/10.1016/j.ijsu.2011.10.001.
10. Rothwell PM. External validity of randomized controlled trials: "to whom do the results of this trial apply?". Lancet. 2005; 365:82–93.
11. Shin CM, Han CS, Pae CU, Patkar AA. Tools for quality evaluation of clinical research reports. Korean J Psychopharmacol. 2011; 22:67–72.
12. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration. Epidemiology. 2007; 18:805–835.
13. Walker W. The strengths and weaknesses of research designs involving quantitative measures. J Res Nurs. 2005; 10:571–582.
Article
14. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. BMJ. 2008; 336:601–605.
http://dx.doi.org/10.1136/bmj.39465.451748.AD.
Article
15. Yoo SH. Reporting guidelines for health promotion research. J Korean Soc Health Educ Promot. 2012; 29:83–99.